Clonazepam 0.5mg Tapering Protocol
For a patient taking 0.5 mg clonazepam daily, reduce the dose by 0.25 mg every 2 weeks until discontinuation, which will take approximately 4 weeks total.
Specific Tapering Schedule
The FDA-approved dosing information indicates that clonazepam should be discontinued gradually with decreases of 0.125 mg to 0.25 mg every 3 days 1. However, clinical research demonstrates that a more conservative approach of 0.25 mg reductions every 2 weeks is safer and better tolerated 2.
Week-by-Week Protocol:
- Weeks 1-2: 0.25 mg daily
- Weeks 3-4: 0.125 mg daily (if available) OR alternate-day dosing of 0.25 mg
- Week 5: Discontinue
Important caveat: The 2016 CDC guidelines specifically recommend a 25% dose reduction every 1-2 weeks for benzodiazepine tapering 3. For your 0.5 mg dose, this translates to the schedule above.
Critical Safety Considerations
Never Abrupt Discontinuation
Abrupt benzodiazepine withdrawal can cause rebound anxiety, hallucinations, seizures, delirium tremens, and rarely death 3. The 2025 joint clinical practice guideline from ASAM and nine other medical societies explicitly states that clinicians should not discontinue BZDs abruptly in patients likely to be physically dependent 4.
Duration of Use Matters
If you have been taking clonazepam for less than 3 months, the above 4-week taper is appropriate. However, if you have been on clonazepam for longer than 1 year, you may need a slower taper extending over several months 2, 4. One study of patients on clonazepam for ≥3 years successfully used a 4-month taper protocol 2.
Withdrawal Symptoms to Monitor
Watch for anxiety, tremor, insomnia, nausea, excessive sweating, tachycardia, headache, weakness, and muscle aches 2. If significant withdrawal symptoms occur, slow the taper rate or pause temporarily 3, 4.
Evidence-Based Modifications
For Longer-Term Users (>1 year)
Research on panic disorder patients taking clonazepam for ≥3 years showed successful discontinuation using 2:
- Decrease by 0.5 mg every 2 weeks until reaching 1 mg/day
- Then decrease by 0.25 mg per week
- Mean starting dose was 2.7 mg/day; 68.9% were medication-free after 4 months
Adjunctive Support
The 2025 ASAM guideline recommends offering psychosocial interventions (such as cognitive behavioral therapy) to support successful tapering 4. CBT specifically increases benzodiazepine tapering success rates 3.
Common Pitfalls to Avoid
Do not use alternate-day dosing at standard doses: Recent 2025 research demonstrates that alternate-day dosing causes pronounced receptor occupancy variation and increases withdrawal risk 5. Only consider this approach when you reach very low doses (0.125 mg or less).
Do not taper too quickly: The 2016 CDC guideline found that a 25% reduction every 1-2 weeks is safer than more rapid tapers 3. A 1999 multicenter study showed that gradual tapering over 7 weeks was well-tolerated without withdrawal syndrome 6.
Do not abandon the patient: The 2025 ASAM guideline emphasizes utilizing shared decision-making and tailoring tapering strategies to each patient 4.
Monitoring Requirements
- Follow-up frequency: At least monthly during the taper 3, 4
- Screen for: Anxiety, depression, and signs of benzodiazepine use disorder 3
- Adjust the taper: Based on withdrawal symptoms and patient tolerance 4
Special Populations
If you are elderly or have liver disease: Start with an even slower taper, as clonazepam undergoes hepatic metabolism and clearance may be impaired 1. The FDA label specifically notes caution in these populations.
If you are pregnant: Do not attempt tapering without specialist consultation due to risks of withdrawal to both mother and fetus 3.